{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:28:15Z","timestamp":1780417695947,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019443","name":"Impulse Dynamics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jchf.2021.04.012","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T21:51:22Z","timestamp":1628718682000},"page":"684-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognostic Importance of Health Status Versus Functional Status in Heart\u00a0Failure and Secondary Mitral Regurgitation"],"prefix":"10.1016","volume":"9","author":[{"given":"Suzanne V.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha S.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2021.04.012_bib1","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.1993.03510140062030","article-title":"Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction","volume":"270","author":"Bittner","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2021.04.012_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCHEARTFAILURE.109.881326","article-title":"Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights","volume":"2","author":"Guazzi","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2021.04.012_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehl527","article-title":"Prognostic value of the 6\u00a0min walk test and self-perceived symptom severity in older patients with chronic heart failure","volume":"28","author":"Ingle","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2021.04.012_bib4","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jacc.2012.08.1010","article-title":"6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure","volume":"60","author":"Forman","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.04.012_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCHEARTFAILURE.112.000291","article-title":"Physical health status measures predict all-cause mortality in patients with heart failure","volume":"6","author":"Chamberlain","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2021.04.012_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/CIRCULATIONAHA.106.670901","article-title":"Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments","volume":"115","author":"Kosiborod","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2021.04.012_bib7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jamacardio.2017.3983","article-title":"Association of Serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials","volume":"2","author":"Pokharel","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2021.04.012_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcin.2018.01.242","article-title":"Inclusion of functional status measures in the risk adjustment of 30-day mortality after transcatheter aortic valve replacement: a report from the Society of Thoracic Surgeons\/American College of Cardiology TVT Registry","volume":"11","author":"Arnold","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jchf.2021.04.012_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002875","article-title":"Association of patient-reported health status with long-term mortality after transcatheter aortic valve replacement: report from the STS\/ACC TVT Registry","volume":"8","author":"Arnold","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jchf.2021.04.012_bib10","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/CIRCULATIONAHA.115.020279","article-title":"Gait speed predicts 30-day mortality after transcatheter aortic valve replacement: results from the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapy Registry","volume":"133","author":"Alfredsson","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2021.04.012_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jacc.2012.10.050","article-title":"Prognostic value of exercise capacity as evaluated by the 6-minute walk test in patients undergoing transcatheter aortic valve implantation","volume":"61","author":"Mok","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.04.012_bib12","doi-asserted-by":"crossref","first-page":"E154","DOI":"10.1002\/ccd.28981","article-title":"Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement","volume":"97","author":"Sathananthan","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jchf.2021.04.012_bib13","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.jacc.2020.03.002","article-title":"Health status changes and outcomes in patients with heart failure and mitral regurgitation: COAPT trial","volume":"75","author":"Arnold","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.04.012_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2018.07.021","article-title":"Cardiovascular outcomes assessment of the MitraClip in patients with heart failure and secondary mitral regurgitation: design and rationale of the COAPT trial","volume":"205","author":"Mack","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2021.04.012_bib15","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2021.04.012_bib16","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.04.012_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jchf.2021.04.012_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/biostatistics\/kxl043","article-title":"Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events","volume":"8","author":"Rondeau","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.jchf.2021.04.012_bib19","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1161\/hcq.13.suppl_1.13","article-title":"Abstract 13: patient-reported health status changes are associated with subsequent clinical outcomes after transcatheter valve therapies: insights from the STS\/TVT registry","volume":"13","author":"Hejjaji","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2021.04.012_bib20","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/CIRCULATIONAHA.113.007477","article-title":"Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial","volume":"129","author":"Arnold","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2021.04.012_bib21","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.jacc.2016.07.762","article-title":"Prediction of poor outcome after transcatheter aortic valve replacement","volume":"68","author":"Arnold","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2021.04.012_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007564","article-title":"Defining a clinically important change in 6-minute walk distance in patients with heart failure and mitral valve disease","volume":"14","author":"Jain","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2021.04.012_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCOUTCOMES.113.000354","article-title":"How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the PARTNER trial","volume":"6","author":"Arnold","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2021.04.012_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/HCR.0000000000000507","article-title":"Exercise training effects on the relationship of physical function and health-related quality of life among older heart failure patients with preserved ejection fraction","volume":"40","author":"Brubaker","year":"2020","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jchf.2021.04.012_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2011.09.027","article-title":"Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure","volume":"163","author":"Flynn","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2021.04.012_bib26","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.jcin.2020.07.030","article-title":"Baseline functional capacity and transcatheter mitral valve repair in heart failure with secondary mitral regurgitation","volume":"13","author":"Malik","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177921002237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177921002237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T09:27:44Z","timestamp":1718789264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177921002237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2213177921002237"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2021.04.012","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Importance of Health Status Versus Functional Status in Heart\u00a0Failure and Secondary Mitral Regurgitation","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2021.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}